Opportunistic salpingectomy, or the removal of fallopian tubes in women already undergoing another abdominal or gynecological ...

In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...

Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.

More than two-thirds of deaths from ovarian cancer are attributable to high-grade serous carcinoma. In one particularly ...

NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in ...

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Ovarian cancer reprograms the omentum to shield hidden tumors. New research suggests total omentectomy may curb recurrence and improve long-term outcomes.

TAIPEI (Taiwan News) — Kaohsiung Chang Gung Memorial Hospital performed its first ovarian tissue freezing surgery at the end ...

A nurse from Medway battling ovarian cancer who recently outlined her bucket list to Boston 25 News received the ultimate ...